 BioXcel Therapeutics, Inc. NASDAQ:BTAI Q2 2022 Earnings Conference Call August 9, 2022 8:30 AM ET Company Participants Vimal Mehta - Chief Executive Officer Founder Richard Steinhart - Senior Vice President and Chief Financial Officer Matt Wiley - Chief Commercial Officer Robert Risinger - Chief Medical Officer, Neuroscience Frank Yocca - Chief Scientific Officer Vincent ONeill - Senior Vice President Chief Medical Officer, Oncology Conference Call Participants Greg Harrison - Bank of America Robyn Karnauskas - Truist Securities Sumant Kulkarni - Canaccord Colin Bristow - UBS Richard Allen - Mizuho Securities Ram Selvaraju - H.C. Wainwright Corinne Jenkins - Goldman Sachs Operator Good morning and welcome to the BioXcel Therapeutics Second Quarter 2022 Financial Results Conference Call. 